Department of Medicine, Georgia Health Sciences Univ., Augusta, GA 30912, USA.
Am J Physiol Regul Integr Comp Physiol. 2012 Jan 15;302(2):R274-82. doi: 10.1152/ajpregu.00546.2011. Epub 2011 Nov 2.
NADPH oxidase has been implicated in ANG II-induced oxidative stress and hypertension in males; however, the contribution of oxidative stress to ANG II hypertension in females is unknown. In the present study, we tested the hypothesis that greater antioxidant capacity in female spontaneously hypertensive rats (SHR) blunts ANG II-induced oxidative stress and hypertension relative to males. Whole body and renal cortical oxidative stress levels were assessed in female and male SHR left untreated or following 2 wk of chronic ANG II infusion. Chronic ANG II infusion increased NADPH oxidase enzymatic activity in the renal cortex of both sexes; however, this increase only reached significance in female SHR. In contrast, male SHR demonstrated a greater increase in all measurements of reactive oxygen species production in response to chronic ANG II infusion. ANG II infusion increased plasma superoxide dismutase activity only in female SHR (76 ± 9 vs. 190 ± 7 Units·ml(-1)·mg(-1), P < 0.05); however, cortical antioxidant capacity was unchanged by ANG II in either sex. To assess the functional implication of alterations in NADPH enzymatic activity and oxidative stress levels following ANG II infusion, additional experiments assessed the ability of the in vivo antioxidant apocynin to modulate ANG II hypertension. Apocynin significantly blunted ANG II hypertension in male SHR (174 ± 2 vs. 151 ± 1 mmHg, P < 0.05), with no effect in females (160 ± 11 vs. 163 ± 10 mmHg). These data suggest that ANG II hypertension in male SHR is more dependent on increases in oxidative stress than in female SHR.
NADPH 氧化酶已被牵涉到 ANG II 诱导的雄性氧化应激和高血压中;然而,氧化应激对雌性 ANG II 高血压的贡献尚不清楚。在本研究中,我们检验了这样一个假设,即雌性自发性高血压大鼠 (SHR) 中更大的抗氧化能力会减轻 ANG II 诱导的氧化应激和高血压,相对于雄性。在未经处理或接受慢性 ANG II 输注 2 周的雌性和雄性 SHR 中,评估了全身和肾皮质的氧化应激水平。慢性 ANG II 输注增加了两性肾皮质的 NADPH 氧化酶酶活性;然而,这种增加仅在雌性 SHR 中达到显著水平。相比之下,雄性 SHR 在对慢性 ANG II 输注的反应中表现出更大的所有活性氧产生测量值的增加。ANG II 输注仅在雌性 SHR 中增加了血浆超氧化物歧化酶活性(76 ± 9 与 190 ± 7 单位·ml(-1)·mg(-1),P < 0.05);然而,皮质抗氧化能力在两性中均不受 ANG II 的影响。为了评估 ANG II 输注后 NADPH 酶活性和氧化应激水平变化的功能意义,进行了额外的实验来评估体内抗氧化剂 apocynin 调节 ANG II 高血压的能力。apocynin 显著减轻了雄性 SHR 的 ANG II 高血压(174 ± 2 与 151 ± 1 mmHg,P < 0.05),而对雌性无影响(160 ± 11 与 163 ± 10 mmHg)。这些数据表明,雄性 SHR 的 ANG II 高血压比雌性 SHR 更依赖于氧化应激的增加。